Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Waldencast plc

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

ACQUISITION STRENGTHENS OBAGI MEDICAL'S PRODUCT PORTFOLIO WITH PROVEN, SCIENTIFICALLY BACKED, INJECTABLE PORTFOLIO NEW PRODUCTS POSITION OBAGI MEDICAL AT THE FOREFRONT OF HEALTH, BEAUTY AND AESTHETICS CONVERGENCE LONDON, JULY 23, 2025 (GLOBE NEWSWIRE) -- WALDENCAST PLC (NASDAQ: WALD) (WALDENCAST), A GLOBAL MULTI-BRAND BEAUTY AND WELLNESS PLATFORM, TODAY ANNOUNCED THAT IT HAS ACQUIRED NOVAESTIQ CORP. (NOVAESTIQ), A GROWTH-ORIENTED AESTHETIC AND MEDICAL DERMATOLOGICAL INNOVATIONS COMPANY, AS WELL AS THE U.S. RIGHTS TO THE SAYPHA LINE OF HYALURONIC ACID (HA) INJECTABLE GELS. THE STRATEGIC ACQUISITION EXPANDS OBAGI MEDICAL'S OFFERINGS BEYOND U.S. MEDICAL-GRADE SKINCARE, A MARKET PROJECTED TO BE $2.2 BILLION BY 2029, INTO THE GROWING U.S. DERMAL FILLER MARKET, PROJECTED TO REACH $2 BILLION IN MARKET SIZE BY 2029, EFFECTIVELY DOUBLING ITS ADDRESSABLE MARKET.1 THE MOVE MARKS A PIVOTAL STEP IN POSITIONING OBAGI MEDICAL AS AN INDUSTRY LEADER IN INTEGRATED SKINCARE AND AESTHETIC SOLUTIONS.

WALDENCAST ACQUIRES NOVAESTIQ CORP. AND U.S. RIGHTS TO LEADING INJECTABLE HYALURONIC ACID GEL LINE, SAYPHA, UNDER THE OBAGI MEDICAL BRAND

Q1 NET REVENUE OF $65.4 MILLION, (4.1)% DECLINE FROM Q1 202476.4% ADJUSTED GROSS MARGIN, AN IMPROVEMENT OF 10 BASIS POINTS$4.4 MILLION OF ADJUSTED EBITDA

WALDENCAST REPORTS Q1 2025 FINANCIAL RESULTS

LONDON, MAY 06, 2025 (GLOBE NEWSWIRE) -- WALDENCAST PLC, (NASDAQ: WALD) (WALDENCAST), A GLOBAL MULTI-BRAND BEAUTY AND WELLNESS PLATFORM PROVIDED THE DETAILS FOR ITS FIRST QUARTER FISCAL 2025 CONFERENCE CALL AND WEBCAST. AS PREVIOUSLY ANNOUNCED, THE COMPANY WILL ISSUE ITS FIRST QUARTER FISCAL 2025 RESULTS ON MAY 13, 2025 AFTER THE CLOSE OF THE U.S. MARKET.

WALDENCAST PLC ANNOUNCES FIRST QUARTER FISCAL 2025 RESULTSCONFERENCE CALL AND WEBCAST

A SCIENTIFIC BREAKTHROUGH IN SKIN RENEWAL: A CLINICALLY PROVEN DUAL-ACTION, SLOW-RELEASE, OVERNIGHT SKIN RENEWAL CREAM FOR A RESURFACED, SMOOTHER, AND MORE EVEN-LOOKING COMPLEXION

OBAGI MEDICAL ANNOUNCES THE LAUNCH OF RETINOL + PHA REFINING NIGHT CREAM

Q4 NET REVENUE OF $72.1 MILLION, 29.4% COMPARABLE NET REVENUE GROWTH AND $11.2 MILLION OF ADJUSTED EBITDA, DOUBLING FROM Q4 2023

WALDENCAST REPORTS Q4 2024 AND FISCAL YEAR 2024 FINANCIAL RESULTS

LONDON, MARCH 11, 2025 (GLOBE NEWSWIRE) -- WALDENCAST PLC, (NASDAQ: WALD) (WALDENCAST), A GLOBAL MULTI-BRAND BEAUTY AND WELLNESS PLATFORM PROVIDED THE DETAILS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2024 CONFERENCE CALL AND WEBCAST. AS PREVIOUSLY ANNOUNCED, THE COMPANY WILL ISSUE ITS FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS ON MARCH 18, 2025 AFTER THE CLOSE OF THE U.S. MARKET.

WALDENCAST PLC ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS CONFERENCE CALL AND WEBCAST

NEW SKINCARE SOLUTIONS TO TARGET SKIN BRIGHTENING, OXIDATIVE STRESS, AND HYDRATION FOR A HEALTHIER, MORE RADIANT COMPLEXION NEW SKINCARE SOLUTIONS TO TARGET SKIN BRIGHTENING, OXIDATIVE STRESS, AND HYDRATION FOR A HEALTHIER, MORE RADIANT COMPLEXION

OBAGI MEDICAL ANNOUNCES THE LAUNCH OF LATEST INNOVATIONS IN THE SUZANOBAGIMD COLLECTION

LONDON, JAN. 30, 2025 (GLOBE NEWSWIRE) -- WALDENCAST PLC, (NASDAQ: WALD) (WALDENCAST), A GLOBAL MULTI-BRAND BEAUTY AND WELLNESS PLATFORM, ANNOUNCED UPCOMING EARNINGS RELEASE, CONFERENCE CALL AND WEBCAST INFORMATION FOR THE FOURTH QUARTER AND FULL FISCAL YEAR 2024 AND FIRST, SECOND, AND THIRD QUARTERS OF FISCAL YEAR 2025. THE WEBCASTS WILL BE AVAILABLE ON THE INVESTOR RELATIONS PAGE ON THE COMPANY'S WEBSITE AT HTTPS://IR.WALDENCAST.COM/APPROXIMATELY 2 WEEKS PRIOR TO THE EVENTS.

WALDENCAST PLC ANNOUNCES UPCOMING EARNINGS RELEASE AND CONFERENCE CALL DATES

LONDON, JAN. 29, 2025 (GLOBE NEWSWIRE) -- WALDENCAST PLC, (NASDAQ: WALD) (WALDENCAST), A GLOBAL MULTI-BRAND BEAUTY AND WELLNESS PLATFORM, TODAY ANNOUNCED ITS PARTICIPATION IN THE 2025 INTERNATIONAL MASTER COURSE ON AGING SCIENCE (IMCAS) WORLD CONGRESS, WHICH WILL BE HELD IN PARIS FROM JANUARY 30, 2025 TO FEBRUARY 1, 2025.

WALDENCAST ANNOUNCES PARTICIPATION IN THE 2025 IMCAS WORLD CONGRESS

THE NEW YORK CITY BASED AWARD-WINNING CLEAN COLOR COSMETICS BRAND WILL EXPAND TO SELECT ULTA BEAUTY STORES NATIONWIDE AND ONLINE, MARKING A SIGNIFICANT MILESTONE SINCE ITS DEBUT IN 2016 NEW YORK , JAN. 28, 2025 /PRNEWSWIRE/ -- MILK MAKEUP, THE TRAILBLAZING CLEAN BEAUTY BRAND CELEBRATED FOR ITS ICONIC, HIGH-PERFORMANCE FORMULAS, INCLUSIVE ETHOS AND PART OF THE WALDENCAST PLC (NASDAQ: WALD) PLATFORM, IS THRILLED TO ANNOUNCE AN EXPANSION INTO THE NATION'S LARGEST BEAUTY RETAILER, ULTA BEAUTY. BEGINNING THIS SPRING, MILK MAKEUP'S CULT-FAVORITE PRODUCTS, INCLUDING THE 13X AWARD-WINNING HYDRO GRIP PRIMER AND INTERNET-BREAKING COOLING WATER JELLY TINTS WILL BE AVAILABLE IN 600+ ULTA BEAUTY STORES NATIONWIDE AND ON ULTA.COM.

Waldencast plc

WALD

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Waldencast plc

WALD.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

WALD